|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01276 HENGRUI PHARMA
Nominal 
46.460 -1.740 (-3.610%) Ranking Overview
Ranking based on 8 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
1
|
Buy (2)
6
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 119.00 RMB (cts) | |
| Net Profit | 7,711.06 RMB (MIL) | DPS | 20.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 9,196.00 | 138.45 | 14.25 | -- | 10,049.00 | 7,986.00 |
| 2027 | 10,307.00 | 155.50 | 14.25 | -- | 12,523.00 | 8,670.00 |
| 2028 | 12,309.50 | 185.50 | 19.01 | -- | 15,151.00 | 9,905.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 10,049.00 | 151.00 | -- | CITIC SEC | Buy | 99.00 | 13/05/2026 | |
| 2026 | 9,180.00 | 138.00 | 24.00 | UBS | Buy | 92.10 | 24/07/2026 | |
| 2026 | 8,874.30 | 134.00 | 14.25 | MORGAN STANLEY | Overweight | 92.00 | 19/08/2026 | |
| 2026 | 9,212.00 | 138.90 | -- | BOCOM | Neutral | 74.00 | 24/04/2026 | |
| 2026 | 9,256.00 | 139.00 | -- | NOMURA | Buy | 73.85 | 21/08/2026 | |
| 2026 | 7,986.00 | 125.00 | 30.00 | HSBC | Buy | 73.70 | 20/08/2026 | |
| 2026 | 8,785.00 | 132.00 | -- | JP MORGAN | Overweight | 68.00 | 06/08/2026 | |
| 2026 | 9,763.00 | 148.70 | -- | DAIWA | Buy | 60.00 | 20/08/2026 | |
| 2027 | 12,523.00 | 189.00 | -- | CITIC SEC | -- | -- | 13/05/2026 | |
| 2027 | 10,351.00 | 156.00 | 27.00 | UBS | -- | -- | 24/07/2026 | |
| 2027 | 10,263.00 | 155.00 | 14.25 | MORGAN STANLEY | -- | -- | 19/08/2026 | |
| 2027 | 11,001.00 | 165.90 | -- | BOCOM | -- | -- | 24/04/2026 | |
| 2027 | 9,157.00 | 138.00 | -- | NOMURA | -- | -- | 21/08/2026 | |
| 2027 | 8,670.00 | 136.00 | 32.00 | HSBC | -- | -- | 20/08/2026 | |
| 2027 | 10,564.00 | 159.00 | -- | JP MORGAN | -- | -- | 06/08/2026 | |
| 2027 | 8,894.00 | 135.00 | -- | DAIWA | -- | -- | 20/08/2026 | |
| 2028 | 15,151.00 | 228.00 | -- | CITIC SEC | -- | -- | 13/05/2026 | |
| 2028 | 12,098.00 | 182.00 | 31.00 | UBS | -- | -- | 24/07/2026 | |
| 2028 | 12,521.00 | 189.00 | 19.01 | MORGAN STANLEY | -- | -- | 19/08/2026 | |
| 2028 | 13,035.00 | 196.60 | -- | BOCOM | -- | -- | 24/04/2026 | |
| 2028 | 10,782.00 | 162.00 | -- | NOMURA | -- | -- | 21/08/2026 | |
| 2028 | 9,905.00 | 155.00 | 37.00 | HSBC | -- | -- | 20/08/2026 | |
| 2028 | 12,908.00 | 194.00 | -- | JP MORGAN | -- | -- | 06/08/2026 | |
| 2028 | 10,650.00 | 161.20 | -- | DAIWA | -- | -- | 20/08/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 24/08/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,465,439 |
| %Change | 0.345% |
| EPS / (LPS) | RMB 0.680 |
| NBV Per Share (¥) | RMB 9.713 |